Video

What to Consider Before Choosing a Melanoma Treatment Plan

Author(s):

Claire Friedman, MD

Claire Friedman, Memorial Sloan Kettering Cancer Center, discusses some of the factors that doctors and elderly patients with melanoma should discuss before deciding on a treatment plan with immunotherapy. Immunotherapy is not one-size-fits all, and patients should be informed of the pros and cons of each option.

Claire Friedman, Memorial Sloan Kettering Cancer Center, discusses some of the factors that doctors and elderly patients with melanoma should discuss before deciding on a treatment plan with immunotherapy. Immunotherapy is not one-size-fits all, and patients should be informed of the pros and cons of each option.

Related Videos
Image of a man with short black hair.
Image of a woman with tied back hair, wearing pearl earrings.
Image of a woman with layered hair, wearing a bright blue cardigan.
Image of a man with short black hair.
Image of man with gray hair.
Image of woman with black hair.
Image of a man wearing a black suit and tie.
Image of a man with white hair and a white goatee.
Image of a woman with brown wavy hair, wearing a navy blue top.
Image of a man wearing a suit with a red bowtie.
Related Content
Illustration of a person with breast cancer.
October 11th 2024

‘The Office’ Actress Opens Up About Breast Cancer, Martha Davis Cancels Concerts After Radiation and More

Alex Biese Ashley Chan
From Jenna Fischer announcing her breast cancer diagnosis to Martha Davis and the Motels canceling concerts after her radiation therapy, here’s what’s happening in the cancer space this week.
CURE Cancer Horizons logo
February 26th 2024

FDA Approvals from February 2024

Alex Biese Brielle Benyon
February brought in multiple FDA approvals in the oncology space. Here’s an overview of some of the most recent ones.
Image of a doctor examining a patient's skin.
October 2nd 2024

Longer Time Until Recurrence Associated With Better Melanoma Outcomes

Alex Biese
An expert explains study findings that associate a longer time until postsurgical melanoma recurrence with improved progression and survival.
Top Cancer Headlines from 2023
January 2nd 2024

Top Cancer Headlines from 2023

Alex Biese Brielle Benyon
From Jimmy Buffett's death to the chemo shortage and cannabis use in cancer care, here is a look back at some of our most popular oncology stories from 2023.
FDA Approves Subcutaneous Tecentriq Formulation
September 12th 2024

FDA Approves Subcutaneous Tecentriq Formulation

Darlene Dobkowski, MA
Tecentriq Hybreza, a subcutaneous delivery of the drug, was approved for certain types of sarcoma, in addition to lung, skin and liver cancers.
Image of the FDA logo with a light blue background.
September 5th 2024

FDA to Speed Up Review of IBI363 for Advanced Melanoma

Brielle Benyon
The Food and Drug Administration granted a fast track designation to IBI363 for patients with unresectable advanced or metastatic melanoma.